May 14, 2015
Fitch, Even, Tabin & Flannery LLP is pleased to announce that Alan E. Schiavelli, Donald E. Stout, and James A. Zak have joined the firm in our Washington, D.C. office. All three come to us from an IP law boutique based in Arlington, Virginia.
Alan E. Schiavelli has over 25 years of experience in strategically preparing and prosecuting patent applications for clients in the U.S., Japan, and Europe, as well as providing validity and infringement opinions, trademark availability studies and prosecution, and IP infringement litigation support. Al’s clients range from small businesses to large global corporations involved in industries that include chemicals and chemical engineering, oil and gas research, and the mechanical arts, among others.
Donald E. Stout’s intellectual property law practice spans over 40 years and encompasses experience in nearly all facets of patent law, including patent prosecution, portfolio management, licensing, and litigation. He often offers counsel to clients on strategies for monetizing patents. Don has primarily worked with large multinational corporations that deal with telecommunications, electrical power generation, semi-conductor technologies, computer software and hardware, and mechanical engineering.
James A. Zak chiefly focuses his practice on the intersection of intellectual property and FDA law. He often works with startups in FDA-regulated industries, particularly medical devices, to develop and align their IP and FDA market approval strategies while simultaneously developing robust patent portfolios. James has also represented clients in the chemical, biotechnology, pharmaceutical, mechanical engineering, and computer software and hardware industries. His prior experience includes over six years serving as in-house counsel at a medical device company in Minnesota.
Their combined decades of experience, notable legal acumen, and exceptional dedication to client service make them a valued addition to the Fitch Even team.
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more